Cost-Effectiveness of Combination Disease-Modifying Antirheumatic Drugs Versus Tumor Necrosis Factor Inhibitors in Active Rheumatoid Arthritis: A Pragmatic, Randomized, Multicenter Trial

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)
307 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Cost-Effectiveness of Combination Disease-Modifying Antirheumatic Drugs Versus Tumor Necrosis Factor Inhibitors in Active Rheumatoid Arthritis: A Pragmatic, Randomized, Multicenter Trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions